LIXT: Lixte Biotechnology Holdings, Inc. Stock

by  •  • Comments Off on LIXT: Lixte Biotechnology Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.70
Enterprise Value ($M) 4.56
Book Value ($M) 1.37
Book Value / Share 0.61
Price / Book 1.97
NCAV ($M) 1.36
NCAV / Share 0.60
Price / NCAV 1.98

Profitability (mra)
Return on Invested Capital (ROIC) -2.93
Return on Assets (ROA) -0.93
Return on Equity (ROE) -1.00

Liquidity (mrq)
Quick Ratio 5.13
Current Ratio 5.13

Balance Sheet (mrq) ($M)
Current Assets 1.69
Assets 1.70
Liabilities 0.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-18 13G Intracoastal Capital, Llc 4.99
02-18 13G/A Orca Capital AG 4.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 4,481 13,094 34.22
2025-03-06 577 9,309 6.20
2025-03-05 4,876 20,190 24.15
2025-03-04 3,466 13,395 25.88

(click for more detail)

Similar Companies
LFVN – LifeVantage Corporation LGVN – Longeveron Inc.
LIPO – Lipella Pharmaceuticals Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io